Contributors to mortality in high-risk diabetic patients in the Diabetes Heart Study

Amanda J Cox1, Fang-Chi Hsu2, Barry I Freedman3

  • 1Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC.

Diabetes Care
|July 4, 2014
PubMed

Insights

Individuals with type 2 diabetes and high coronary artery calcification (CAC) face varying mortality risks. Modifiable cardiovascular disease (CVD) risk factors, including vascular calcification, significantly impact outcomes in this high-risk group.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Type 2 diabetes (T2D) and high coronary artery calcification (CAC) identify individuals at elevated cardiovascular disease (CVD) risk.
  • Risk stratification within this high-risk cohort remains crucial for personalized management.
  • Variability in adverse outcomes suggests other contributing factors beyond CAC alone.

Purpose of the Study:

  • To investigate the association between modifiable cardiovascular disease (CVD) risk factors and all-cause mortality in individuals with type 2 diabetes (T2D) and high coronary artery calcification (CAC).
  • To determine if traditional CVD risk factors provide additional prognostic information in a high-risk T2D population with CAC >1,000 mg.

Main Methods:

  • A cohort of 371 European American individuals with T2D and CAC >1,000 mg from the Diabetes Heart Study (DHS) was followed for 8.2 ± 3.0 years.
  • Cox proportional hazards regression models were employed to analyze all-cause mortality.
  • Differences in CVD risk factors between survivors and non-survivors were compared.

Main Results:

  • Higher vascular calcified plaque scores were significantly associated with increased mortality risk (HR 1.31-1.63).
  • Elevated HbA1c, lipids, C-reactive protein, and reduced kidney function also correlated with increased mortality risk (HR 1.1-1.5).
  • Deceased participants had longer T2D duration and lower use of cholesterol-lowering medications.

Conclusions:

  • Vascular calcification and modifiable CVD risk factors offer valuable prognostic information for risk assessment in high-risk T2D patients.
  • The use of cholesterol-lowering medication demonstrated a protective effect against mortality in this cohort.
Abstract

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
15
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
51
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
28
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
23